Business Wire

NC-DOLE-FOOD-NC

Share
Dole Food Company Gives 2.2 Million Pounds of Fresh Produce to Communities in Need

Dole Food Company announced today that in an effort to help with the COVID-19 crisis, Dole and its associated growers have so far donated more than two million pounds of fresh produce to recipients along its supply chain, from local food banks in the U.S. to the communities in Latin America.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200416005885/en/

“The virus is ruthless, and we have seen the brutal impact it has had on people—directly to their health and their income,” stated Johan Linden, CEO of Dole Food Company. “We want to answer the needs of the communities around our operations and do what we can to strengthen them during this moment of hardship.”

Dole recognizes these donations alone will not solve the food needs issue brought on by the coronavirus, but believes that we should all do what we can to help those around us. Dole is committed to continuing these efforts during this crisis.

Vince Hall, CEO of Feeding San Diego, an organization whose mission is to connect every person facing hunger with nutritious meals, shared his comments on Dole’s actions.

“While medical providers and first responders battle the COVID-19 crisis, Feeding San Diego is battling unprecedented hunger across San Diego County. One of our most important allies in this fight is Dole Food Company, a significant employer at the Port of San Diego. Dole continues to regularly donate large amounts of nutritious fresh fruit, especially bananas, which are very popular in the community and contribute to good health. Dole is to be commended for helping Feeding San Diego take care of those in need all year round, but especially during the current health crisis.”

In addition to San Diego, Dole has made donations in other U.S. cities including New York, Philadelphia, Charlotte, Houston, Los Angeles.

In Latin America, where Dole grows its tropical fruits, such as bananas and pineapple, the crisis is also hitting hard, and the company is supporting those rural communities where food security is most at risk. In the Aguan Valley of Honduras, for example, in addition to fruit Dole is distributing household staples such as rice, beans and cooking oil to employees and local communities. Beyond food, the company is also providing masks, sanitizing gel, testing kits and other health supporting supplies. Similar support is happening for communities in Costa Rica, Ecuador, Guatemala and Colombia including the provision of over 15,000 personal hygiene kits to aid in the prevention of infection.

“As an important local employer, it is our duty to support local communities. The consequences of this crisis are just starting to be felt here and the need for social support will continue to be felt in the weeks and months to come,” stated Renato Acuña, President of Dole Fresh Fruit Latin America. “Our local foundations and those of our associated producers are actively working on the ground and on the front line of this crisis, and Dole will provide additional support as long as necessary.”

The Dale Foundation, funded by Dole and its Ecuadorian growers, is using its medical staff and facilities to get the word out to the community on the importance of COVID-19 prevention, identifying high risk citizens to help them undertake the proper care, advancing purchases of medication that can help with respiratory illness, and continuing to operate its health clinics and provide remote medical services for its patients in the agricultural community.

Dole is also supporting those working on the front lines of the crisis by donating to hospitals in various countries where it operates and working with civil authorities to provide local aid.

For example, in the U.S., Dole has joined national produce distributor PRO*ACT, and other produce partners, to bring fresh produce to the tables of healthcare workers and their families during the COVID-19 crisis. The ‘Feeding our Frontlines’ program (www.producepartners.org ) provides boxes of fresh produce for healthcare employees to take home at the end of a long shift as a way of saying “thank you” to those taking care of us."

About Dole Food Company

Dole Food Company, Inc., is one of the world’s largest producers and marketers of high-quality fresh fruit and fresh vegetables. Dole is an industry leader in many of the products it sells, as well as in nutrition education. For more information, please visit www.dole.com .

Social Media:

https://www.facebook.com/dole

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lone Star Announces Sale of SPX FLOW to ITT Inc.5.12.2025 13:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced the signing by an affiliate of Lone Star Fund XI, LP of a definitive agreement to sell SPX FLOW, Inc. (“SPX FLOW”), a leading provider of highly engineered equipment and process technologies for attractive end markets including industrial, health and nutrition, to ITT Inc. (NYSE: ITT) for $4.775 billion in cash and shares of common stock. Based in Charlotte, N.C., SPX FLOW focuses on process technologies delivering mixing, blending, fluid handling, separation, thermal heat transfer and other solutions integral to industrial, health and nutrition markets. The company has operations in more than 25 countries and sales in more than 140 countries. In partnership with Lone Star, SPX FLOW has focused on improving its sales execution and operating platform, while ensuring high quality and innovative product development. The management team has improved the company’s commercial organization and executed growth initiatives to build its presence in e

AmTrust Financial Services and Blackstone Credit & Insurance Close Strategic Transaction and Launch Newly Formed Multinational MGACompany Named ANV Group Holdings Ltd.5.12.2025 13:00:00 CET | Press release

Strategic Transaction Unlocks Value for AmTrust and Positions ANV Group Holdings for Accelerated GrowthFormer AmTrust President Adam Karkowsky Leading ANV Group Holdings as Chairman and CEO AmTrust Financial Services, Inc. (“AmTrust” or the “Company”), a global specialty property casualty insurer, and Blackstone Credit & Insurance (“BXCI”), today announced the closing of a strategic transaction under which AmTrust and funds managed by BXCI have partnered to spin-off certain of AmTrust’s Managing General Agencies (“MGAs”) and fee-based businesses in the U.S., United Kingdom, and Continental Europe, into ANV Group Holdings Ltd. (“ANV”), a newly formed independent company, following receipt of regulatory approvals. AmTrust and ANV have entered into a ten-year capacity agreement through which AmTrust will remain the underwriter for the existing books of business offered through the MGAs. As previously announced on September 15, 2025, the agreement includes seven AmTrust subsidiaries: ANV S

Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body5.12.2025 07:00:00 CET | Press release

Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1 Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs The certification validates Sculptra’s safety performance, efficacy, and quality, reinforcing Galderma’s commitment to innovation and meeting evolving patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its

Northern Escape Heli-Skiing Takes the Title of “World’s Best Heli-Ski-Operator” for the 4th Year Running5.12.2025 02:40:00 CET | Press release

4x World’s Best Heli-Skiing Operation near Terrace, BC Northern Escape Heli-Skiing (NEH) has been named World’s Best Heli-Ski Operator 2025 by the World Ski Awards, marking its fourth straight victory following years 2022, 2023 and 2024. This recognition places NEH amongst an elite group of ski tourism operators consistently voted best in the world by industry leaders and enthusiasts alike. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204074550/en/ A four-year run built on reliability NEH operates in British Columbia’s Skeena Mountains, where deep northern snow and vast terrain come together with small-group heli-skiing and heli snowboarding. When helicopters can’t safely fly, NEH has cat skiing readily available as a backup — an exceedingly rare offering in this industry. The operation spans over 833,571 wild acres of alpine bowls, glaciers and old-growth tree skiing. The NEH experience Guests choose from three lodge f

IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance5.12.2025 01:00:00 CET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollment in Q1 2026, initially evaluating patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck, and ovarian/gynecological cancers. IDE034 is a bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and licensed to IDEAYA in July 2024. The IND clearance marks an important milestone for this licensed program, supporting subsequent clinical development of IDE034, while highlighting Biocytogen’s technical capabilities in bispecific ADC discovery and development. Dr. Yue

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye